0

UNTIRE App for Cancer-Related Fatigue

NN
Overseen ByNina N Grenon, DNP, AOCN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This research is being done to find out if using a smartphone app as digital treatment to reduce Cancer Related Fatigue is feasible and easy to use.This research study is evaluating a smartphone application named the "Untire" app. The Untire app was designed as a digital treatment plan for people experiencing Cancer Related Fatigue (CRF).

Research Team

NN

Nina N Grenon

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

This trial is for adults over 18 with recurrent colorectal cancer who are currently undergoing treatment. Participants must own a smartphone or iPad, be able to read and speak English at a basic level, and experience fatigue related to their cancer.

Inclusion Criteria

Owns a smart phone or iPad
A score of 1 or greater on the PRO CTACE DFCI fatigue (questions 53a or 53b)
Speak and read English at a 6th grade level or higher
See 2 more

Exclusion Criteria

Patients in Surveillance
I am taking dexamethasone for reasons other than nausea control.
I am taking Ritalin for cancer-related fatigue.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Untire app as a self-managed digital treatment for cancer-related fatigue, with check-in meetings to assess app usage and progress

12 weeks
Check-in meetings at weeks 4, 8, and 12

Follow-up

Participants are monitored for safety and effectiveness after treatment, with a final check-in 6 months post baseline

6 months
Final check-in 6 months post baseline

Treatment Details

Interventions

  • UNTIRE App
Trial Overview The study is testing the 'Untire' app, designed as a digital tool to help manage Cancer Related Fatigue (CRF) in patients with colorectal cancer. The research will assess if the app is user-friendly and effective in reducing fatigue.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: UNTIRE AppExperimental Treatment1 Intervention
At baseline meeting participants will answer questionnaires and be introduced and instructed on self-managed use of Untire app treatment program. Participants will then have check in meetings assessing app usage and progress on weeks 4, 8 and 12 post baseline, then a final check-in 6 months post baseline.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security